Malondialdehyde in cognitive impairment: A systematic review and meta-analysis
Authors:
Open Access
- 20 December 2025
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 181, 106531
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrierAgeing Research Reviews, 2024
- Resistin and omentin in breast cancer: A systematic review and meta-analysisClinica Chimica Acta, 2024
- Positive association of a Sirt1 variant and parameters of oxidative stress on Alzheimer’s diseaseNeurological Sciences, 2020
- DNA methylation of the RE-1 silencing transcription factor in peripheral blood mononuclear cells and gene expression of antioxidant enzyme in patients with late-onset Alzheimer diseaseExperimental Gerontology, 2020
- Elevated platelet microparticles levels are associated with lipidic oxidation and inflammatory profiles in Alzheimer's diseaseEuropean Geriatric Medicine, 2016
- Evaluation of Selenium, Redox Status and Their Association with Plasma Amyloid/Tau in Alzheimer’s DiseaseBiological Trace Element Research, 2014
- Metalloproteinase’s Activity and Oxidative Stress in Mild Cognitive Impairment and Alzheimer’s DiseaseNeurochemical Research, 2008
- Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, TurkeyClinical Biochemistry, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Mild Cognitive Impairment Represents Early-Stage Alzheimer DiseaseArchives of Neurology, 2001